Akums Drugs shares surged 5% in early trade on Monday after the company reported strong financial performance for the first quarter of FY27. The company posted healthy year-on-year growth in net profit, revenue and EBITDA, supported by improved operating performance.
Akums Drugs Q1 Results: Key Highlights
Akums Drugs reported a 57.5% year-on-year increase in consolidated net profit to ₹100 crore, compared with ₹63.5 crore in the corresponding quarter last year.
The company's revenue from operations increased 13.9% YoY to ₹1,167 crore, from ₹1,024 crore a year ago.
EBITDA also witnessed strong growth, rising 35.5% YoY to ₹175 crore, compared with ₹129 crore in the year-ago period. The EBITDA margin improved to 15% from 12.6%, indicating an improvement in operational profitability.
Akums Drugs Share Price Today
Following the Q1 results, Akums Drugs shares surged nearly 5% in morning trading. As of 10:45 AM, the stock was trading around ₹750, against the previous close of ₹697.45.
The stock touched an intraday high of ₹750.55, which also marked its 52-week high, while the day's low stood at ₹703. The stock opened at ₹710.10.
Akums Drugs' 52-week low is ₹409.30, highlighting the significant recovery in the stock over the past year. Trading volume stood at around 11.36 lakh shares as of 10:45 AM.
The strong Q1 performance, particularly the sharp rise in net profit and EBITDA margin, has supported positive sentiment around Akums Drugs shares in Monday's trading session.